Cook Medical is presenting its latest advancements at the ISET 2010 International Symposium on Endovascular Therapy. In addition to live and simulated device demonstrations in booth #208, Cook's activities at the meeting include data presentations from two ongoing clinical trials and breakout sessions on common and debilitating conditions such as varicocele.
Rob Lyles, vice president and global leader of Cook's peripheral intervention business unit said, The number of people affected by some form of peripheral vascular disease is increasing at alarming rates worldwide,” said Rob Lyles, vice president and global leader of Cook's peripheral intervention business unit. Awareness is a fundamental line of attack for us against these spiking numbers. It is our mission to inform patients and physicians alike about the intricacies surrounding treatments that span the entire vascular disease spectrum and arm them with the technologies needed to improve outcomes.